Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

April Smith

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2008
The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)Geoffrey B Varty, Sherry X Lu, Cynthia A Morgan, et al.
Journal of Medicinal Chemistry|January 5, 2007
Metabolism-based identification of a potent thrombin receptor antagonistMartin C Clasby, Samuel Chackalamannil, Michael Czarniecki, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxietyGinny D Ho, John Anthes, Ana Bercovici, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 3, 2024
American society for metabolic and bariatric surgery: intra-operative care pathway for minimally invasive Roux-en-Y gastric bypassHenry Lin, John W Baker, Katherine Meister, et al.
European Journal of Pharmacology|December 17, 2009
Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical modelsRobbie L McLeod, Deen B Tulshian, Donald C Bolser, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2008
The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)Geoffrey B Varty, Sherry X Lu, Cynthia A Morgan, et al.
Journal of Medicinal Chemistry|January 5, 2007
Metabolism-based identification of a potent thrombin receptor antagonistMartin C Clasby, Samuel Chackalamannil, Michael Czarniecki, et al.
Bioorganic & Medicinal Chemistry Letters|April 3, 2009
The discovery of tropane derivatives as nociceptin receptor ligands for the management of cough and anxietyGinny D Ho, John Anthes, Ana Bercovici, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 3, 2024
American society for metabolic and bariatric surgery: intra-operative care pathway for minimally invasive Roux-en-Y gastric bypassHenry Lin, John W Baker, Katherine Meister, et al.
European Journal of Pharmacology|December 17, 2009
Pharmacological profile of the NOP agonist and cough suppressing agent SCH 486757 (8-[Bis(2-Chlorophenyl)Methyl]-3-(2-Pyrimidinyl)-8-Azabicyclo[3.2.1]Octan-3-Ol) in preclinical modelsRobbie L McLeod, Deen B Tulshian, Donald C Bolser, et al.
Pageof 5